## Summary

The paper introduces **HYPOGENEAGENT**, an LLM-driven framework that transforms cluster annotation and resolution selection in single-cell/Perturb-seq analysis into a quantitatively optimizable task. An LLM agent generates ranked GO hypotheses for each cluster’s gene signature; these hypotheses are embedded and used to compute intra-cluster agreement and inter-cluster distinctiveness, which are combined into a single Resolution Score. The method is validated on a K562 CRISPRi Perturb-seq dataset, where the agent-selected resolution is claimed to align better with known biology than traditional metrics such as silhouette score, modularity, and functional enrichment analysis.

## Strengths

- **Novel integration of LLM reasoning with resolution selection.** The idea of using LLM-generated functional annotations to guide clustering hyperparameter choice is original and addresses a real gap in single-cell analysis pipelines.
- **Principled metric design.** The definitions of intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD) based on semantic similarity of LLM hypotheses are clear and provide a natural way to quantify biological coherence.
- **Thorough parameter benchmark (Stage 1).** The authors systematically compare embedding methods, prompt designs, LLM backbones, and temperature settings on curated GOBP gene sets, providing useful guidance for practitioners.
- **Application at both gene-expression and perturbation levels.** The method is demonstrated on two distinct clustering tasks (GEX clusters and perturbation clusters), showing its potential versatility.

## Weaknesses

### Fatal
None.

### Major

1. **Validation on a single dataset.** The entire Stage 2 evaluation is performed on one K562 Perturb-seq dataset (Replogle et al., 2022). Without results on additional datasets (e.g., different cell types, tissues, or technologies), the generalizability of the approach remains unsubstantiated. The paper’s claims of broad applicability are not supported.

2. **No quantitative ground truth for resolution selection.** The paper asserts that the Resolution Score selects a “biologically meaningful” resolution, but there is no quantitative benchmark against a known ground-truth clustering or a gold-standard annotation. The comparison with traditional metrics (silhouette, modularity) merely shows that different metrics pick different resolutions; it does not demonstrate that the agent’s choice is objectively better. The UMAP visualizations are qualitative and insufficient to support the claim of superior biological interpretability.

3. **Circular validation with functional enrichment analysis (Section 4.4.3).** The authors apply the same ICS/ICD/Resolution Score metrics to the results of standard functional enrichment analysis and claim consistency. This is not an independent validation—it simply shows that the same metric applied to a different annotation method yields similar resolution choices. A proper comparison would require an external biological benchmark (e.g., recovery of known cell types or perturbation effects).

4. **Sensitivity to the weight hyperparameter \(w\) is underexplored.** The weight \(w = 1/3\) is chosen by a “small grid search,” but the paper does not report how robust the optimal resolution is to changes in \(w\). Figure S5 (mentioned in text) shows that different clusters respond differently to \(w\), but the impact on the final resolution selection is not analyzed. This is a critical hyperparameter that could significantly affect results.

5. **Lack of comparison to other automated resolution selection methods.** The paper cites MultiK (Liu et al., 2021) and other tools in the related work but does not compare HYPOGENEAGENT against them. A baseline comparison with MultiK or other cluster-validation indices (e.g., gap statistic, prediction strength) would strengthen the evaluation.

6. **Computational cost and reproducibility concerns.** The method relies on proprietary, expensive LLMs (GPT-o3) and embedding models (text-embedding-3-large). The paper does not report the total API cost or runtime, nor does it discuss how the approach scales to larger datasets (e.g., Human Cell Atlas). This limits reproducibility and practical adoption.

### Minor

- The paper states that the Resolution Score is “maximized when clusters exhibit simultaneous coherence and mutual exclusivity,” but the formula \(\text{RS}_k = w\text{ICS}_k + (1-w)(1-\text{ICD}_k)\) is defined per cluster, not globally. The global resolution selection is based on the median or mean of \(\text{RS}_k\) across clusters. The aggregation method should be stated more clearly.
- The description of the clustering procedure (Section 3.2) is vague and refers to the appendix, which is stripped. The reader cannot assess the preprocessing or clustering details.
- The paper claims “orders of magnitude faster than manual curation” but provides no timing data to support this.
- The writing contains some unclear passages (e.g., “the agent referee panel score” in the abstract is not defined until later).

### Trivial

- The conclusion section uses “HypoGenAgent” (missing ‘e’) inconsistently with the title.
- Some figure references in the text (e.g., “Figure 1: Three box plots (a, b, c) showing the effect of different concentrations of 1,25-(OH)2D3…”) are clearly parser artifacts from another paper. While this is a formatting issue, it suggests the PDF extraction was imperfect.

## Nice-to-Haves

- A comparison with a simpler baseline that uses standard GO enrichment (e.g., Fisher’s exact test) to compute ICS/ICD would help isolate the value of the LLM component.
- An ablation study that replaces the LLM-generated hypotheses with random or fixed GO terms would test whether the semantic similarity signal is meaningful.
- A discussion of the failure cases or limitations of the LLM (e.g., hallucinations, bias toward well-studied pathways) would improve the paper’s credibility.

## Novel Insights

None beyond the paper’s own contributions. The core idea of using LLM-generated annotation consistency for resolution selection is novel, but the experimental validation does not yet yield deeper insights into when or why this approach outperforms traditional methods.

## Suggestions

1. **Validate on multiple datasets** from different tissues, species, and technologies (e.g., PBMC, brain, mouse data) to demonstrate generalizability.
2. **Provide a quantitative ground-truth benchmark** for resolution selection, such as recovering known cell-type labels or perturbation effects (e.g., using F1 score or adjusted Rand index against a trusted annotation).
3. **Compare against existing automated resolution selection tools** (e.g., MultiK, Clustree) and report standard cluster-quality metrics (e.g., ARI, NMI) for the chosen resolution.
4. **Perform a sensitivity analysis** for the weight \(w\) and report how the optimal resolution changes across a range of \(w\) values.
5. **Report computational cost** (API calls, time, cost) and discuss scalability to larger datasets.
6. **Make the code and prompts publicly available** to facilitate reproducibility.

## Score and Decision

The paper presents a creative and timely idea, but the experimental validation is insufficient to support the strong claims. The single-dataset evaluation, lack of quantitative ground truth, and absence of comparisons to existing methods leave the contribution unsubstantiated. The method has potential, but in its current form the evidence is not compelling enough for acceptance.

**Score:** 4.0

**Decision:** Reject

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>